Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma.

MLA

Ninosu, Nadia, et al. “Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-Cell Lymphoma.” Cancers, vol. 16, no. 1, Jan. 2024, p. 141. EBSCOhost, https://doi.org/10.3390/cancers16010141.

APA

Ninosu, N., Melchers, S., Kappenstein, M., Booken, N., Hansen, I., Blanchard, M., Guenova, E., Assaf, C., Goerdt, S., & Nicolay, J. P. (2024). Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma. Cancers, 16(1), 141. https://doi.org/10.3390/cancers16010141

Chicago

Ninosu, Nadia, Susanne Melchers, Max Kappenstein, Nina Booken, Inga Hansen, Maël Blanchard, Emmanuella Guenova, Chalid Assaf, Sergij Goerdt, and Jan P. Nicolay. 2024. “Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-Cell Lymphoma.” Cancers 16 (1): 141. doi:10.3390/cancers16010141.